NewsBenzingaSeaStar Medical Reports 65.1% Survival Rate At Day 90 In Its QUELIMMUNE SAVE Registry Analysis Presented At ASN Kidney Week 2026 SeaStar Medical Reports 65.1% Survival Rate At Day 90 In Its QUELIMMUNE SAVE Registry Analysis Presented At ASN Kidney Week 2026 Benzinga 2026.10.22 16:05 (GMT+0) Open on Benzinga Other news Hawkins (HWKN) Shares Rise 12% After-Hours: Here's Why A-Share Close: ChiNext Index Opens Higher, Closes Down Over 3% as More Than 4,900 Stocks Fall Market-Wide Novartis Keeps FY 2026 Net Sales Growth At Low Single-Digit, Raises Core Operating Income Outlook To In Line To Low Single-Digit Growth Gilat Satellite Networks: Lenders Bet On $16, The Stock Sits At $7.44 (NASDAQ:GILT) Novartis Q3 Adj. EPS $2.46 Beats $2.27 Estimate, Sales $14.522B Miss $14.582B Estimate Disney And Channel 4 Announce Agreement To Offer Linear Channel, On-Demand Catalogue And Day-And-Date Shows On Disney+ In UK And Ireland From Early 2027 At No Extra Cost
A-Share Close: ChiNext Index Opens Higher, Closes Down Over 3% as More Than 4,900 Stocks Fall Market-Wide
Novartis Keeps FY 2026 Net Sales Growth At Low Single-Digit, Raises Core Operating Income Outlook To In Line To Low Single-Digit Growth
Disney And Channel 4 Announce Agreement To Offer Linear Channel, On-Demand Catalogue And Day-And-Date Shows On Disney+ In UK And Ireland From Early 2027 At No Extra Cost
